<--- Back to Details
First PageDocument Content
Mutation / Genetic disorder / Point mutation / Beta-thalassemia / Carcinogenesis / Genotype / Human genome / Chromosome 1 / Cystic fibrosis / Biology / Genetics / Philosophy of biology
Date: 2009-09-01 14:32:19
Mutation
Genetic disorder
Point mutation
Beta-thalassemia
Carcinogenesis
Genotype
Human genome
Chromosome 1
Cystic fibrosis
Biology
Genetics
Philosophy of biology

ANNEX Hereditary effects of radiation CONTENTS Page

Add to Reading List

Source URL: chernobyl.undp.org

Download Document from Source Website

File Size: 2,12 MB

Share Document on Facebook

Similar Documents

Hemoglobins / Hemoglobin E / Sickle-cell disease / Gene therapy / Hemoglobin / Beta thalassemia / Thalassemia / Mucositis

Marina Cavazzana [Mode de compatibilité]

DocID: 1p4cO - View Document

Blood / Hematopathology / RTT / Hematology / Thalassemia / Anemias / Beta thalassemia / Management of thalassemia / Sickle-cell disease / Blood transfusion / Red blood cell / Chelation therapy

I would like to donate Name ............................................................................................... Diagnostic Lab Thalassemia & Sickle Cell Society Vuppala Krishna Rao & Chandrakala Diagnostic

DocID: 1oVFa - View Document

Hemoglobins / Sickle-cell disease / Sickle cell trait / Hemoglobin / Red blood cell / Scd / Hemoglobin C / Sickle cell-beta thalassemia

Sickle Cell Awareness Sickle Cell Disease (SCD) is an assembly of inherited red blood cell disorders. People with SCD have abnormal hemoglobin, termed as hemoglobin S or sickle hemoglobin, in their red blood cells. Inhe

DocID: 1onjc - View Document

Beta Thalassemia Genetic Testing Interpretation Order Form Patient´s name (first name, last name)

DocID: 1crRW - View Document

Hematology / Anemias / Hematopathology / Celgene / Myelodysplastic syndrome / Beta-thalassemia / Transforming growth factor beta / Thalassemia / Diamond–Blackfan anemia / Medicine / Health / Biology

CORPORATE FACT SHEET December 2013 Acceleron is a biopharmaceutical company committed to discover, develop, manufacture and commercialize novel protein therapeutics for cancer and orphan diseases Acceleron’s scientific

DocID: 19vEv - View Document